Latest News
CHINA YUCHAI INTERNATIONAL TO ANNOUNCE UNAUDITED 2025 FIRST-HALF YEAR FINANCIAL RESULTS ON AUGUST 8, 2025
- Earnings Call to Begin at 8:00 A.M. EDT – SINGAPORE, July 28, 2025 /PRNewswire/ -- China Yuchai International Limited (NYSE: CYD) ("China Yuchai" or the "Company"), announced today that it will be releasing its 2025 unaudited first-half year financial results onFriday, August 8, 2025 before t...
Daqo New Energy Issues Its 2024 Environmental, Social and Governance (ESG) Report
SHANGHAI, July 28, 2025 /PRNewswire/ -- Daqo New Energy Corp. (NYSE: DQ) ("Daqo New Energy," the "Company" or "we"), a leading manufacturer of high-purity polysilicon for the global solar PV industry, today published its 2024 Environmental, Social and Governance ("ESG") report. The 2024 ESG rep...
2025 World Internet Conference Digital Silk Road Development Forum Opens in Quanzhou
QUANZHOU, China, July 28, 2025 /PRNewswire/ -- A news report from CRI Online:
Quhuo Partners with NIU World to Launch Innovative Fresh Beef Chain Brand Incubation Platform, Accelerating the Transformation of China's Fresh Beef Consumption Market
BEIJING, July 28, 2025 /PRNewswire/ -- Quhuo Limited (NASDAQ: QH) ("Quhuo" or the "Company"), a leading tech-enabled service platform, today announced a strategic partnership with NIU World, a local food group inChina, to jointly establish a new chain brand incubation platform focused on fresh be...
Caliway Announces FDA Clearance of IND Application for CBL-514 to Proceed with SUPREME-01, the First Global Pivotal Phase 3 Study for Reducing Abdominal Subcutaneous Fat
* CBL-514, Caliway's first-in-class lipolysis drug candidate, has been granted clearance from the U.S. FDA to proceed with SUPREME-01, a global, multicenter, pivotal Phase 3 study. Subject recruitment is expected to begin in the U.S. andCanada in Q3 2025. * CBL-514 is the first 505(b)(1) inve...
FinVolution Group Publishes Seventh Annual ESG Report
SHANGHAI, July 28, 2025 /PRNewswire/ -- FinVolution Group ("FinVolution," or the "Company") (NYSE: FINV), a leading fintech platform, today announced it has released its 2024 Environmental, Social, and Governance (ESG) report, the Company's seventh consecutive annual ESG report. The report provid...
Cheetah Mobile to Acquire Controlling Stake in UFACTORY to Accelerate Its Robotics Commercialization Strategy
BEIJING, July 28, 2025 /PRNewswire/ -- Cheetah Mobile Inc. (NYSE: CMCM) ("Cheetah Mobile" or the "Company"), aChina-based IT company, today announced that one of its majority-owned subsidiaries has signed a definitive agreement to acquire an equity interest of 60.8% in Shenzhen UFACTORY Technolog...
Last Chance to Get COSRX's Best-Selling Snail Duo on the House at Alfred Coffee -- This Wednesday Only
LOS ANGELES, July 28, 2025 /PRNewswire/ -- It's the glow-up everyone's been
talking about. This July, cult K-beauty favoriteCOSRX
Doosan Robotics Accelerates Push to Become an AI Robot Solutions Leader
— Acquires 89.59% stake in U.S. automation engineering firm ONExia — Strengthens future growth engine with AI•humanoid technology•top-tier talent and builds an R&D Innovation center EXTON, Pa. and SEONGNAM, South Korea, July 28, 2025 /PRNewswire/ -- Doosan Robotics is stepping up its transformati...
Beijing Review: The Across the Pacific: China-U.S. Youth Dialogue for a Shared Future program concluded in Shanghai.
BEIJING, July 28, 2025 /PRNewswire/ -- On July 22, the Across the Pacific: China-U.S. Youth Dialogue for a Shared Future program officially came to a close inShanghai.   The story never ends! On July 22, the Across the Pacific: China-#US Youth Dialogue for a Shared Future pr...
The 2025 China-ASEAN Education Cooperation Week Held in Guizhou
GUIYANG, China, July 28, 2025 /PRNewswire/ -- This is a report from Discover Guizhou: On July 26, the opening ceremony of the 2025 China-ASEAN Education Cooperation Week (CAECW) was held at the permanent venue of the China-ASEAN Education Cooperation Week in Gui'an New Area,Guiyang, Guizhou. The...
Alteogen Receives Positive CHMP Opinion for Aflibercept Biosimilar, 'EYLUXVI® (ALT-L9)'
* CHMP positive opinion is based on a robust analytical, non-clinical and clinical data package comparing EYLUXVI® to the reference product Eylea® * Upon approval, EYLUXVI® will be Alteogen's second biosimilar product, following a Herceptin® biosimilar by Alteogen's license partner Qilu Pharm...
DIGITIMES ASIA: Nvidia explores SOCAMM deployment for next-gen AI systems
TAIPEI, July 23, 2025 /PRNewswire/ -- Nvidia is preparing to enter a new phase in the memory market by planning to deploy between 600,000 and 800,000 SOCAMM modules in 2025. This initiative positions SOCAMM as a potential successor to high-bandwidth memory (HBM). Although the initial deployment v...
NMPA Accepts sNDA for Ivonescimab in Combination with Chemotherapy as First-Line Treatment for Advanced Squamous Non-Small Cell Lung Cancer
HONG KONG, July 28, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the National Medical Products Administration (NMPA) has accepted the supplementary New Drug Application (sNDA) for ivonescimab (PD-1/VEGF bispecific antibody) in combination with ...
Ascletis Announces First Participants with Obesity or Overweight Dosed in Its U.S. 12-week Phase IIa Study Evaluating Once-Monthly Subcutaneous Depot Formulation of Small Molecule GLP-1R Agonist ASC30
- First participants with obesity or overweight with at least one w eight-related comorbidity have been dosed in a U.S. 12-week Phase IIa study with once-monthly subcutaneous (SQ) depot formulation of small molecule GLP-1 receptor agonist ASC30. - Ultra-long-acting SQ depot for...
Harbour BioMed Announces Positive Profit Alert for 2025 Interim Results
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, July 27, 2025 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company focused on the discovery and development of novel antibody therapeutics in immunology and oncology, today announced a positive prof...
Breakthrough in Light Therapy: KouShiCare utilizes DWV™LLLT Technology to Treat Dry Eyes
HONG KONG, July 27, 2025 /PRNewswire/ -- KouShiCare, a leading innovator in healthcare technology, is proud to announce a groundbreaking advancement in the treatment of dry eye disease. The company's latest device harnesses the power of DWV™ Low-Level Laser Therapy (LLLT) technology, marking a si...
New Yorkers immerse in incredible Shanghai culture
SHANGHAI, July 27, 2025 /PRNewswire/ -- A news report from
english.shanghai.gov.cn
Global Times: How 'investing in the people' benefits the whole society in China
BEIJING, July 27, 2025 /PRNewswire/ -- Recently, many friends and I purchased new home appliances. Statistics show that more than 100 million home appliances have been replaced through the consumer goods trade-in program this year. With generous subsidies fueling a consumption boom, could this be...
To advance China-US trade ties with sincerity, principles: Global Times
BEIJING, July 27, 2025 /PRNewswire/ -- A new round of China-US economic and trade talks is set to be held inSweden from Sunday to Wednesday. This follows a series of significant consensuses reached inGeneva and the establishment of a framework during talks inLondon. At a time when the global econ...
Week's Top Stories
Most Reposted
Tonik Becomes the First Standalone Digital Bank in the Philippines to Achieve Profitability
[Picked up by 297 media titles]
2026-05-12 10:15Visa amps up the music as Official Payment Partner for the Asia leg of The Weeknd's 'After Hours Til Dawn' Stadium Tour
[Picked up by 295 media titles]
2026-05-11 16:20Avnet and HKSTP Invite Global Startups to New AI Hardware Launchpad
[Picked up by 292 media titles]
2026-05-12 10:00Hong Leong Bank Awarded Best Managed Bank in Malaysia by The Asian Banker, Group MD/CEO Kevin Lam Named Best Bank CEO in Malaysia
[Picked up by 286 media titles]
2026-05-15 17:00Peach Blossoms Celebrates Three Massive Wins - Black Pearl Restaurant Guide 2026, Asia's 50 Best Restaurants 2026 Extended List and Tatler Best 20 Restaurants in Singapore 2026
[Picked up by 285 media titles]
2026-05-12 14:00